Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Two transplant patients on cyclosporine unexpectedly developed hair loss.